Pages that link to "Q54416919"
Jump to navigation
Jump to search
The following pages link to Inflammatory Cytokine Induced Regulation of Superoxide Dismutase 3 Expression by Human Mesenchymal Stem Cells (Q54416919):
Displaying 35 items.
- Activation, homing, and role of the mesenchymal stem cells in the inflammatory environment (Q28067094) (← links)
- Mesenchymal Stem Cells Regulate the Innate and Adaptive Immune Responses Dampening Arthritis Progression (Q28078360) (← links)
- Novel treatment of neuroinflammation against low back pain by soluble fullerol nanoparticles (Q30417501) (← links)
- Primary progressive multiple sclerosis: progress and challenges. (Q30590258) (← links)
- Mesenchymal stem cells restore frataxin expression and increase hydrogen peroxide scavenging enzymes in Friedreich ataxia fibroblasts (Q34053510) (← links)
- Pullulan hydrogels improve mesenchymal stem cell delivery into high-oxidative-stress wounds (Q34150243) (← links)
- Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases (Q34176532) (← links)
- Mesenchymal Stem Cells and Inflammatory Cardiomyopathy: Cardiac Homing and Beyond (Q34635689) (← links)
- Oxidative stress, redox regulation and diseases of cellular differentiation (Q35611511) (← links)
- The cerebrospinal fluid proteome in HIV infection: change associated with disease severity (Q35965332) (← links)
- The Favorable Effect of Mesenchymal Stem Cell Treatment on the Antioxidant Protective Mechanism in the Corneal Epithelium and Renewal of Corneal Optical Properties Changed after Alkali Burns (Q36530413) (← links)
- Mesenchymal stem cells, aging and regenerative medicine (Q36883559) (← links)
- Wharton’s Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adult Mesenchymal Stem Cells for the Treatment of Type 1 Diabetes (Q37802776) (← links)
- Mesenchymal stromal cell 'licensing': a multistep process (Q37880625) (← links)
- Inflammation and mesenchymal stem cell aging (Q37894245) (← links)
- Mesenchymal stromal cells for tissue-engineered tissue and organ replacements (Q37976114) (← links)
- Mesenchymal stem cells as treatment for MS - progress to date. (Q38057682) (← links)
- Feasibility of cell therapy in multiple sclerosis: a systematic review of 83 studies (Q38186029) (← links)
- Systemic impact molds mesenchymal stromal/stem cell aging (Q38440883) (← links)
- Oxidative stress-related biomarkers in multiple sclerosis: a review (Q38841957) (← links)
- Mesenchymal Stem Cell-Derived Factors Restore Function to Human Frataxin-Deficient Cells (Q40956615) (← links)
- Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment. (Q41486306) (← links)
- Suppression of Neutrophil-Mediated Tissue Damage-A Novel Skill of Mesenchymal Stem Cells (Q41524707) (← links)
- Mechanisms of T-cell immunosuppression by mesenchymal stromal cells: what do we know so far? (Q42103653) (← links)
- Lower serum extracellular superoxide dismutase levels are associated with polyneuropathy in recent-onset diabetes (Q47134766) (← links)
- Evidence for augmented oxidative stress in the subjects with type 1 diabetes and their siblings: a possible preventive role for antioxidants (Q47400131) (← links)
- Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases (Q47619959) (← links)
- Enhanced stem cell engraftment and modulation of hepatic reactive oxygen species production in diet-induced obesity (Q47914694) (← links)
- A Graphene Quantum Dots-Hypochlorite Hybrid System for the Quantitative Fluorescent Determination of Total Antioxidant Capacity (Q48034426) (← links)
- Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis (Q49343380) (← links)
- Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells. (Q55065461) (← links)
- Adipose stem cells and their paracrine factors are therapeutic for early retinal complications of diabetes in the Ins2 mouse (Q59329644) (← links)
- Human mesenchymal stem cells increase anti-oxidant defences in cells derived from patients with Friedreich's ataxia (Q84606936) (← links)
- Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study (Q88170532) (← links)
- Insights into superoxide dismutase 3 in regulating biological and functional properties of mesenchymal stem cells (Q90014175) (← links)